A retrospective, observational, cohort study to investigate the risk of cardiovascular and skeletal outcomes associated with Zoledronic-acid use for osteoporosis in real world users using Danish and Swedish health registries
Latest Information Update: 08 Jun 2021
At a glance
- Drugs Zoledronic acid (Primary) ; Bisphosphonates
- Indications Osteoporosis
- Focus Adverse reactions
Most Recent Events
- 08 Jun 2021 New trial record